mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0016 |
1 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.0013 |
1 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.0013 |
1 |
mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
0.001 |
1 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
-0.0012 |
1 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
1 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.0014 |
1 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.00088 |
1 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.00075 |
1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00081 |
1 |